Palo Alto Investors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001306923

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 29 positions · Total reported value $1.06B · Top-10 concentration 88.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.8% · 4 new · 25 cut · 0 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.7% · vs SPY -4.8% · Prev Value $723.72M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.2% · vs SPY -5.3% · Latest Value $672.15M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Palo Alto Investors LP disclosed 29 equity positions with a combined reported value of $1.06B. The filing implies a focused portfolio: its ten largest positions account for 88.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were BMRN ($162.01M), INSM ($148.71M), UTHR ($130.08M). By sector, the heaviest allocations are Health Care 77.6%, Financials 1.9%.

Versus the prior quarter, Palo Alto Investors LP opened 4 new positions, trimmed 25 and fully exited 0, a turnover rate of 51.8% of positions.

The largest new positions opened in Q3 2023 were BMRN ($162.01M), INSM ($148.71M), UTHR ($130.08M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • BMRN BIOMARIN PHARMACEUTICAL INC · $162.01M
  • INSM INSMED INC · $148.71M
  • UTHR UNITED THERAPEUTICS CORP DEL · $130.08M
  • FOLD AMICUS THERAPEUTIC · $127.97M
  • BIIB BIOGEN INC · $97.99M
  • PRTA PROTHENA CORP PLC · $79.97M
  • RVNC REVANCE THERAPEUTICS INC · $59.97M
  • STAA STAAR SURGICAL CO · $55.24M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Palo Alto Investors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Palo Alto Investors LP, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 56 positions worth $672.15M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-58166 (status: Approved), registered 2000-12-05
  • Regulatory AUM (Form ADV): $696.00M as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds
  • Website: pa-investors.com

Portfolio Structure

  • 56 positions · $672.15M reported value (Q3 2026)
  • Top 10 holdings = 59.9% of reported value
  • Largest position: PTCT (PTC THERAPEUTICS INC) at 8.4%
  • Average position size: $12.00M

Sector Tilt

  • Health Care 99.8%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 4 new, 10 added, 25 reduced
  • 17 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 77.6%
Financials 1.9%
Other 20.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.83M $162.01M 15.33%
15.33%
New
2 5.89M $148.71M 14.07%
14.07%
New
3 575.91K $130.08M 12.31%
12.31%
New
4 10.52M $127.97M 12.11%
12.11%
New
5 381.28K $97.99M 9.27%
9.27%
New
6 1.66M $79.97M 7.57%
7.57%
New
7 5.23M $59.97M 5.67%
5.67%
New
8 1.37M $55.24M 5.23%
5.23%
New
9 2.41M $50.14M 4.74%
4.74%
New
10 1.01M $20.70M 1.96%
1.96%
New
11 2.74M $20.27M 1.92%
1.92%
New
12 55.70K $17.01M 1.61%
1.61%
New
13 603.40K $16.90M 1.60%
1.60%
New
14 94.03K $11.40M 1.08%
1.08%
New
15 660.27K $10.66M 1.01%
1.01%
New
16 431.22K $7.74M 0.73%
0.73%
New
17 5.68M $7.61M 0.72%
0.72%
New
18 386.83K $7.43M 0.70%
0.70%
New
19 472.60K $6.86M 0.65%
0.65%
New
20 6.53M $5.44M 0.52%
0.52%
New
21 111.72K $3.29M 0.31%
0.31%
New
22 732.40K $2.20M 0.21%
0.21%
New
23 64.70K $2.04M 0.19%
0.19%
New
24 166.07K $1.48M 0.14%
0.14%
New
25 278.99K $1.21M 0.11%
0.11%
New
26 160.80K $1.07M 0.10%
0.10%
New
27 656.20K $780.88K 0.07%
0.07%
New
28 27.10K $380.75K 0.04%
0.04%
New
29 24.50K $343.25K 0.03%
0.03%
New

FAQ

What did Palo Alto Investors LP buy in 2023-Q3?

In its 2023-Q3 13F filing, Palo Alto Investors LP reported 29 equity positions worth $1.06B in aggregate; its largest disclosed positions were BMRN ($162.01M), INSM ($148.71M), UTHR ($130.08M).

How large is Palo Alto Investors LP's portfolio?

Palo Alto Investors LP reported $1.06B of long equity holdings across 29 positions as of 2023-Q3. Top-10 holdings account for 88.3% of reported value.

What is Palo Alto Investors LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/palo-alto-investors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →